Ikarian Capital, LLC Bright Minds Biosciences Inc. Transaction History

Ikarian Capital, LLC

  • $247 Million
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
BUY
$1.44 - $3.37 $8,579 - $20,078
5,958 Added 5.96%
105,958 $161,000
Q4 2021

Feb 14, 2022
BUY
$3.17 - $8.23 $317,000 - $823,000
100,000 New
100,000 $317,000

About BRIGHT MINDS BIOSCIENCES INC.

DRUG Quotes by TradingView
  • Ticker DRUG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,209,900
  • Market Cap $19M
  • Description
  • Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collabor...
More about DRUG
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email